Actinium Pharmaceuticals (NYSE:ATNM) Downgraded by StockNews.com to “Sell”
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Actinium Pharmaceuticals in a research report on Monday. One […]
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Actinium Pharmaceuticals in a research report on Monday. One […]
